retatrutide news today recency 3 What is Retatrutide? Key Facts About 'Triple G'

elilillyco reports P-III (TRIUMPH-1) trial results for triple agonist retatrutide, demonstrating up to 28.3% mean weight loss at 80 weeks and 30.3% at 104 weeks in adults with obesity or overweight without

28.20

★★★★☆4.8 (126)

First Retatrutide phase 3 data, a Triumph of Science!

24.04

★★★★★4.9 (98)

NEW Data drop at #ADA2023: Retatrutide, a triple agonist (GLP1, GIP, glucagon) lost an incredible 24.2% of their body weight, which amounts to 58 lbs! This data suggests retatrutide is the most

24.97

★★★★★5.0 (157)

Initial Reta Phase 3 Trials are in 71lb Avg loss over 68 weeks! : r/ Retatrutide

25.78

★★★★★4.7 (84)

Retatrutide, an experimental drug currently in Phase 3 clinical trials, is nicknamed the Godzilla of weight-loss jabs because of its potential superior efficacy. Developed by Eli Lilly, retatrutide is a triple hormone

26.83

★★★★★4.9 (203)

GLP-3' retatrutide drug delivers major weight loss breakthrough in trials

23.29

★★★★★5.0 (176)

Lilly's Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges

29.56

★★★★★4.8 (132)